Status:
COMPLETED
Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Jessa Hospital
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
testing of autonomic function and relationship with exercise and Qol in diabetic patients and controls
Detailed Description
Cardiovascular autonomic neuropathy is a common (sub)clinical symptom in persons with type 1 diabetes mellitus. Subjects in this non-commercial, monocentric, interventional study undergo autonomic fun...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus (only for the group of subjects with diabetes mellitus)
- At least two years with diagnosis of type 1 diabetes mellitus
- Subject is in a stable condition
- No hospitalization for any reason in the past three months
- 18 years or older
- Being capable of doing physical activities
- Understand the study design and the informed consent
- Sign the informed consent
- No simultaneously participation to another study
- Being capable of moving to the study center
Exclusion
- Uncontrolled hypertension, atrial fibrillation and other cardiovascular conditions
- Severe lung disease
- Muscle deficiency
- Medication with influence on the autonomic nervous system:
- Beta blockers
- Alfa blockers
- Antidepressants
- Non-catecholamines
- (anti) cholinergic medication
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2017
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT03481374
Start Date
July 1 2016
End Date
March 31 2017
Last Update
April 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Ziekenhuis
Hasselt, Belgium, 3500